Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samba Sensors is a Swedish medical technology company specializing in the development of ultra-miniature fiber-optic pressure sensors for life science applications. Their technology allows for high-precision, minimally invasive measurement of physiological parameters such as intracranial, intra-arterial, and intra-cardiac pressure. The company's products are primarily utilized in preclinical research and specialized clinical diagnostics to monitor vital signs in small animal models and human patients. In 2011, Samba Sensors was acquired by Harvard Bioscience, a global developer of solutions for life science research. Today, its sensor technology is integrated into the product offerings of Harvard Bioscience and its subsidiaries, such as Data Sciences International (DSI).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samba Sensors.